BioDrugs
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.5 | Q1 | 94.9% | 2.628 | Q1 | 97.1% |
| 2024 | 6.9 | Q1 | 93.5% | 2.290 | Q1 | 96.4% |
| 2023 | 5.4 | Q1 | 91.6% | 1.796 | Q1 | 94.7% |
| 2022 | 6.8 | Q1 | 92.4% | 1.646 | Q1 | 94.1% |
| 2021 | 7.7 | Q1 | 93.7% | 1.539 | Q1 | 93.4% |
| 2020 | — | — | 1.919 | Q1 | 95.2% | |
| 2019 | — | — | 1.304 | Q1 | 90.5% | |
| 2018 | — | — | 1.601 | Q1 | 92.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1179-190X
ISSN
1173-8804
country
CHcoverage
1996-2026